dc.contributor.author |
Garcia-Sanchez, Tomas |
dc.contributor.author |
Amorós Figueras, Gerard |
dc.contributor.author |
Jorge, Esther |
dc.contributor.author |
Campos, María C. |
dc.contributor.author |
Maor, Elad |
dc.contributor.author |
Guerra, Jose M. |
dc.contributor.author |
Ivorra Cano, Antoni, 1974- |
dc.date.accessioned |
2022-10-13T06:15:47Z |
dc.date.available |
2022-10-13T06:15:47Z |
dc.date.issued |
2022 |
dc.identifier.citation |
García-Sánchez T, Amorós-Figueras G, Jorge E, Campos MC, Maor E, Guerra JM, Ivorra A. Parametric study of pulsed field ablation with biphasic waveforms in an in vivo heart model: the role of frequency. Circ Arrhythm Electrophysiol. 2022. 43 p. DOI: 10.1161/CIRCEP.122.010992 |
dc.identifier.issn |
1941-3149 |
dc.identifier.uri |
http://hdl.handle.net/10230/54363 |
dc.description |
Data de publicació electrónica: 30-09-2022 |
dc.description.abstract |
BACKGROUND:
Pulsed field ablation (PFA) is a novel non-thermal cardiac ablation technology based on
irreversible electroporation. Unfortunately, the characteristics of the electric field waveforms used
in clinical and experimental PFA are not typically reported. This study examines the effect of the
frequency of biphasic waveforms and compares biphasic to monophasic waveforms.
METHODS:
A total of 29 Sprague-Dawley rats were treated with PFA using an epicardial monopolar
electrode. Biphasic waveforms with three different frequencies, 90, 260 and 450 kHz (10 bursts
of 100 µs duration at 500 V or 800 V) and monophasic waveforms (10 pulses of 100 µs duration
at 500 V) were studied. Collateral neuromuscular stimulation and temperature increase in the
point of application were directly measured. Lesion formation was assessed 3 weeks after
treatment by histopathologic analysis. Computer simulations were used to estimate the electric
field lethal threshold for each condition. A previous in vitro study was performed to draw a
complete characterization of the studied dependencies.
RESULTS:
Morphometric analysis demonstrated a significant association between chronic lesion size and
waveform characteristics. For the same voltage level, monophasic waveforms yielded the largest
lesions compared to any of the biphasic protocols (p<0.05). Increasing PFA frequency was
associated with reduced neuromuscular stimulation but also with reduced ablation efficacy.
Maximum absolute temperature increase recorded along a complete treatment was 3 °C. Vascular
structures inside the lesions were preserved for all conditions. Computer simulation-based
analysis showed that waveform frequency had a graded effect on the lethal electric field threshold,
with threshold of 600 V/cm for monophasic waveforms vs. 2000 V/cm for biphasic waveforms
with a frequency of 450 kHz.
CONCLUSIONS:
Frequency is a major determinant of efficacy in biphasic PFA. Our results highlight the critical
need of disclosing waveform characteristics when reporting the results of different PFA systems. |
dc.description.sponsorship |
This work was partially supported by project (PID2019-110120RBI00/AEI/
10.13039/501100011033) from the Ministry of Science, Innovation and Universities and the State
Research Agency of the Spanish government. This project has received funding from the
European Union’s Horizon 2020 research and innovation program under the Marie SkłodowskaCurie grant agreement No 892393 (TACAIRE). Antoni Ivorra gratefully acknowledges financial
support by ICREA under the ICREA Academia program. |
dc.format.mimetype |
application/pdf |
dc.language.iso |
eng |
dc.publisher |
American Hearth Association |
dc.relation.ispartof |
Circulation: Arrhythmia and Electrophysiology. 2022. 43 p. |
dc.rights |
© American Hearth Association http://dx.doi.org/10.1161/CIRCEP.122.010992 |
dc.title |
Parametric study of pulsed field ablation with biphasic waveforms in an in vivo heart model: the role of frequency |
dc.type |
info:eu-repo/semantics/article |
dc.identifier.doi |
https://doi.org/10.1161/CIRCEP.122.010992 |
dc.relation.projectID |
info:eu-repo/grantAgreement/ES/2PE/PID2019-110120RBI00 |
dc.rights.accessRights |
info:eu-repo/semantics/embargoedAccess |
dc.type.version |
info:eu-repo/semantics/acceptedVersion |
dc.embargo.liftdate |
2023-03-30 |
dc.date.embargoEnd |
info:eu-repo/date/embargoEnd/2023-03-30 |